An Unexpectedly High Incidence of Invasive Fungal Diseases in Solid Organ Transplant Recipients on Belatacept for Organ Rejection Prophylaxis: A Single Center Retrospective Cohort Study

Abstract

15% of solid organ transplant recipients on belatacept developed invasive fungal diseases (IFD). The most common IFD were aspergillosis (56%) and candidiasis (22%). The infected cohort was more likely to receive basiliximab, lung transplantation, or identify as White. Higher rates of aspergillosis were seen in this lung cohort than previously reported.